Birthing Ball (Peanut Ball) Positions
Launched by GONCA KARATAŞ BARAN · Jan 27, 2021
Trial Information
Current as of May 23, 2025
Completed
Keywords
ClinConnect Summary
The group of healthy pregnant women who meet the inclusion criteria will be determined by randomization according to the order of application to the delivery room in the latent phase. Positions will be changed every 30 minutes using the peanut ball tool in a group (intervention group) in active phase and transition phase. These positions are; side-lying position, compressed side-lying position, semi-sitting position, forward leaning position, upright sitting position and pushing position. All positions will be given to the pregnant woman by the researcher and she will be with the pregnant w...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Primiparous at 37-42 weeks of gestation,
- • between the ages of 18-40,
- • Not diagnosed with risky pregnancy (Intrauterine Growth Retardation, Fetal Anomaly, Polyhydramnios or Oligohydraamnios, Thromboembolic Diseases, Presentation Anomalies, Premature Membrane Rupture, Multiple Pregnancy, Sexually Transmitted Disease, Preeclampsia / Eclampsia etc.)
- • Without systemic disease (Hypertension, Heart Disease, Diabetes, Asthma, Thyroid, Epilepsy, etc.)
- • Single pregnancy,
- • Vaginal delivery planned with cephalic admission,
- • in the latent phase of labor,
- • Epidural anesthesia / analgesia was not applied,
- • Volunteering to participate in research,
- • Pregnant women who do not have any communication disorder will be taken.
- Exclusion Criteria:
- • Failure to meet the inclusion criteria is the exclusion criteria.
- • Exclusion (Withdrawal) from the Study Criteria
- • Having adaptation problems in applying the positions to be given,
- • Maternal (vital signs deviation from normal, hyperstimulation, abnormal bleeding, etc.) and fetal complications (such as fetal distress, cord entanglement, cord prolapse) during delivery,
- • Caesarean section, which could not complete the normal birth process,
- • Pregnant women who give up working at any stage of the study will be excluded from the study.
About Gonca Karataş Baran
Gonca Karataş Baran is a dedicated clinical trial sponsor with a commitment to advancing medical research and improving patient outcomes. With expertise in managing and overseeing clinical studies, she ensures rigorous adherence to regulatory standards and ethical practices. Her focus spans various therapeutic areas, fostering collaboration among multidisciplinary teams to drive innovation and enhance the efficiency of the clinical trial process. Through her leadership, Gonca aims to contribute significantly to the development of safe and effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, Bilkent, Turkey
Patients applied
Trial Officials
Esma SARIKAYA, professor
Study Director
Ankara City Hospital Bilkent
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials